Lumexa Imaging Holdings, Inc. Common Stock
LMRINASDAQHealthcare● Active
$8.24
$-0.27(-3.12%)
Market Cap$791224853
P/E Ratio—
52W High$19.45
52W Low$6.45
Lumexa Imaging Holdings, Inc. Common Stock (LMRI) · Income Statement
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · LMRI · as of 2026-06-08
Financial statements
Revenue · Gross Profit · Net Income
| Breakdown | 2025-12 | 2024-12 | 2023-12 |
|---|---|---|---|
| Revenue | |||
| Revenue | $1.02B | $0.95B | $0.94B |
| Cost of Revenue | $0.91B | $0.85B | $0.84B |
| Gross Profit | $0.12B | $0.10B | $0.10B |
| Gross Margin %(computed) | 11.45% | 10.15% | 10.57% |
| Operating Expenses | |||
| R&D Expenses | $0.00B | $0.00B | $0.00B |
| G&A Expenses | $0.09B | $0.07B | $0.06B |
| Total Operating Expenses | $0.09B | $0.04B | $0.08B |
| Operating Income | $0.03B | $0.06B | $0.02B |
| Operating Margin %(computed) | 2.61% | 5.82% | 2.40% |
| Interest Income | $0.00B | $0.00B | $0.00B |
| Interest Expense | $0.12B | $0.14B | $0.14B |
| Income Before Tax | ($0.03B) | ($0.08B) | ($0.12B) |
| Income Tax Expense | $0.01B | $0.01B | $0.00B |
| Net Income | ($0.05B) | ($0.09B) | ($0.12B) |
| Net Margin %(computed) | -4.60% | -9.92% | -13.06% |
| Per Share & EBITDA | |||
| EPS (Basic) | $-0.66 | $-1.00 | $-1.29 |
| Wtd Avg Shares | 0.07B | 0.09B | 0.09B |
| EBITDA | $0.08B | $0.11B | $0.09B |
| EBITDA Margin %(computed) | 8.03% | 12.01% | 10.11% |
Data source: Financial Modeling Prep · Last updated: 2026-06-08 · USD · B
Explore more Lumexa Imaging Holdings, Inc. Common Stock data
About Lumexa Imaging Holdings, Inc. Common Stock (LMRI) Income Statement
Lumexa Imaging Holdings, Inc. Common Stock (LMRI) income statement data is sourced from SEC Form 10-K and 10-Q filings. For fiscal year 2025, LMRI reported revenue of $1.02B, gross profit of $0.12B (gross margin 11.45%), and net income of ($0.05B) — a net profit margin of -4.60%.
Frequently asked questions
LMRI · 4 questionsLumexa Imaging Holdings, Inc. Common Stock (LMRI) reported revenue of $1.02B for 2025, up 7.8% year-over-year.
LMRI revenueLMRI salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-08